Learn More
Invitrogen™ ZO-1 Monoclonal Antibody (R26.4C), eBioscience™, Invitrogen™

Rat Monoclonal Antibody
1448.00 NOK - 3210.00 NOK
Specifications
| Antigen | ZO-1 |
|---|---|
| Clone | R26.4C |
| Concentration | 0.5 mg/mL |
| Applications | Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
15547676
|
Invitrogen™
14-9776-80 |
25 μg |
1448.00 NOK
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
15557676
![]() |
Invitrogen™
14-9776-82 |
100 μg |
3210.00 NOK
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Description: The monoclonal antibody R26.4C recognizes the tight junction protein 1, ZO-1 (zona occludens) of rat, mouse, canine, and porcine. ZO-1 is a member of the MAGUK family of tight junction associated scaffolding proteins, each containing a PDZ, SH3 and guanylate kinase-like (GUK) domain. ZO-1 is an integral member of the tight junction complex which forms a barrier to paracellular movement of substances, separating apical and basolateral fluids in relation to the epithelial cell layer. ZO-1 forms complexes with family members ZO-2, ZO-3, as well as occludin, cingulin, claudin-1-8, actin, alpha-catenin, the Ras-effector molecule AF-6, ZONAB, Apg-2, and the junctional adhesion molecules (JAM)-A-C. ZO-1 is thought to anchor the actin cytoskeleton to the tight junction. ZO-1 and ZO-2 have been shown to regulate cell cycle and proliferation with recent evidence highlighting the down-regulation of ZO-1 and ZO-2 with cancer progression. Applications Reported: This R26.4C antibody has been reported for use in western blotting, immunohistochemical staining of frozen tissue sections, microscopy, and immunocytochemistry. Applications Tested: This R26.4C antibody has been tested by immunocytochemistry of formaldehyde-fixed and permeabilized cells and by immunohistochemistry of frozen mouse tissue and can be used at less than or equal to 10 μg/mL. It is recommended that the antibody be carefully titrated for optimal performance in the assay interest.
ZO-1 forms complexes with either ZO-2 or ZO-3. In addition, these proteins can also associate with claudin, occludin and F-actin, at tight junction stands, where they provide a linkage between the actin cytoskeleton and the tight junction. ZO-1 expression is significantly reduced in many breast cancer lines. ZO-2 and ZO-3 are ubiquitously expressed within epithelial tight junctions, and unlike ZO-1, which is also expressed at cell junctions of cardiac myocytes, ZO-2 is not expressed in nonepithelial tissue. ZO-1 is a protein located on a cytoplasmic membrane surface of intercellular tight junctions. ZO-1 may be involved in signal transduction at cell-cell junctions. Two transcript variants encoding distinct isoforms have been identified for the ZO-1 gene. Diseases associated with ZO-1 dysfunction include Celiac Disease and Congenital Nephrotic Syndrome.Specifications
| ZO-1 | |
| 0.5 mg/mL | |
| Monoclonal | |
| Liquid | |
| RUO | |
| PBS with 0.09% sodium azide; pH 7.2 | |
| DKFZp686M05161; I79_005485; MGC133289; OTTHUMP00000174520; Tight junction protein 1; tight junction protein 1 (zona occludens 1); tight junction protein ZO-1; Tjp1; zo1; ZO-1; ZO-1 MDCK; zona occludens 1; zona occludens protein 1; zonula occludens 1; zonula occludens 1 protein; zonula occludens protein 1 | |
| TJP1 | |
| Primary | |
| 4°C | |
| TJP1 |
| R26.4C | |
| Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry | |
| Unconjugated | |
| Rat | |
| Mouse, Rat, Canine | |
| O97758, P39447 | |
| 21872, 292994, 403752 | |
| IgG2a κ | |
| Affinity chromatography | |
| Antibody |
For Research Use Only.
Your input is important to us. Please complete this form to provide feedback related to the content on this product.